Eniware
Chevy Chase, US · Delaware LLC
Eniware develops a power-free, portable sterilization device that adapts Noxilizer's nitrogen dioxide (NO2) sterilant technology to provide sterilization capacity without electricity or water. It targets health professionals delivering safe essential surgery in resource-limited settings such as rural hospitals, refugee camps, military field units, and disaster zones.
Founders & leadership
JB
James BernsteinFounder
HM
Huma MalikFounder
Reported raises · per SEC filings
Form D private placements$2.2M disclosed across 1 round · 2022
▶$2.2MraisedMar 2023 · 4 investors · Other Health CareRule 506(c)
▶$2.2MraisedMar 2023 · 4 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Huma MalikExecutive Officer
- Offering amount
- $5M
- Amount sold
- $2.2M
- Sales commissions
- $400K
- Placement agents
- Carofin, LLC, Carolina Financial Securities, LLC, Carofin
- First sale
- Mar 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Eniware do?
- Eniware develops a power-free, portable sterilization device that adapts Noxilizer's nitrogen dioxide (NO2) sterilant technology to provide sterilization capacity without electricity or water. It targets health professionals delivering safe essential surgery in resource-limited settings such as rural hospitals, refugee camps, military field units, and disaster zones.
- How much funding has Eniware raised?
- Eniware has disclosed $2.2M raised across 1 round.
- Where is Eniware headquartered?
- Eniware is headquartered in Chevy Chase, US.